All In MedTech

Company

Impulse Dynamics

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$312M

3 Form D offerings, 2022 to 2025

Equity

$312M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $84.1M raised of $140M sought, first sale Feb 20, 2025, 20 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Feb 20, 2025Equity$84.1M$140M20Rule 506(b)Form D ↗Mar 6, 2025
Feb 5, 2024Equity$136M$220M11Rule 506(b)Form D ↗May 20, 2024
Feb 11, 2022Equity$91.4M$91.4M26Rule 506(b)Form D ↗Jul 31, 2023

Company details

From the company's latest Form D.

Legal name
Impulse Dynamics plc
Headquarters
Dublin 2, Ireland
Incorporated
Ireland over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    6 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Impulse Dynamics.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT05855135 · 300 participants (planned) · Start May 17, 2023 · Primary completion Dec 31, 2025

      Device: OPTIMIZER® Integra CCM-D System (Treatment Arm) · For: Heart Failure; Heart Failure With Reduced Ejection Fraction; Implantable Defibrillator User and 7 more

      Sites: Glendale, Arizona; Mesa, Arizona; Phoenix, Arizona · 59 sites in all

    • NCT05064709 · 1,500 participants (planned) · Start Feb 3, 2022 · Primary completion Feb 1, 2029

      Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System; OPTIMIZER™ Smart Mini System · For: Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction and 2 more

      Sites: Birmingham, Alabama; Mesa, Arizona; Scottsdale, Arizona · 67 sites in all

    • NCT07209098 · 4,200 participants (planned) · Start Nov 18, 2025 · Primary completion Oct 2030

      Device: Cardiac Contractility Modulation (CCM) · For: Heart Failure and Reduced Ejection Fraction; NYHA Class III Heart Failure

      Sites: Marlton, New Jersey

    8 more trials with a free account

    Reports received

    87

    Received Nov 1, 2025 to Nov 19, 2026

    Malfunction reports

    15

    17% of reports

    Injury reports

    72

    83% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230100
    Jan 243110
    Feb 244110
    Mar 243300
    Apr 242200
    May 241100
    Jun 241010
    Jul 241100
    Aug 242400
    Sep 242100
    Oct 240400
    Nov 241100
    Dec 241200
    Jan 250200
    Feb 250100
    Mar 250300
    Apr 251100
    May 250200
    Jun 250200
    Jul 250200
    Aug 251200
    Sep 250300
    Oct 253000
    Nov 252400
    Dec 252000
    Jan 260500
    Feb 261400
    Mar 260400
    Apr 261500
    May 263200
    Jun 262100
    Jul 261200
    Aug 2613900
    Sep 262300
    Oct 260300
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    3 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.